Tag: standard treatment


Stem cell-based risk scoring tool could predict AML patient’s response to standard treatment

December 8, 2016

Via: The Medical News

The new biomarker is named the LSC17 score as it comes from the leukemia stem cells that drive disease and relapse. These dormant stem cells have properties that allow them to resist standard chemotherapy, which is designed to defeat rapidly […]